GENPREX (GNPX)
(Delayed Data from NSDQ)
$2.53 USD
+0.04 (1.61%)
Updated Jun 11, 2024 03:59 PM ET
After-Market: $2.53 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
D Value C Growth A Momentum D VGM
Brokerage Reports
GENPREX [GNPX]
Reports for Purchase
Showing records 21 - 39 ( 39 total )
Company: GENPREX
Industry: Medical - Biomedical and Genetics
Third Quarter Financial Result Update and REQORSA Patent Granted
Provider: Diamond Equity Research LLC
Analyst: Research Department
Company: GENPREX
Industry: Medical - Biomedical and Genetics
Third Quarter Financial Result Update and REQORSA Patent Granted
Provider: Diamond Equity Research LLC
Analyst: DIAMOND H
Company: GENPREX
Industry: Medical - Biomedical and Genetics
Acclaim 1/2 Trial Progress Supported by Strong Balance Sheet
Provider: Diamond Equity Research LLC
Analyst: DIAMOND H
Company: GENPREX
Industry: Medical - Biomedical and Genetics
Opening enrollment of Acclaim-1 and Acclaim-2 represent major milestones
Provider: Diamond Equity Research LLC
Analyst: DIAMOND H
Company: GENPREX
Industry: Medical - Biomedical and Genetics
Opening enrollment of Acclaim-1 and Acclaim-2 represent major milestones
Provider: Diamond Equity Research LLC
Analyst: DIAMOND H
Company: GENPREX
Industry: Medical - Biomedical and Genetics
Trial Site Openings Accelerating for Catalyst Filled 2022
Provider: Diamond Equity Research LLC
Analyst: DIAMOND H
Company: GENPREX
Industry: Medical - Biomedical and Genetics
Trial Site Openings Accelerating for Catalyst Filled 2022
Provider: Diamond Equity Research LLC
Analyst: DIAMOND H
Company: GENPREX
Industry: Medical - Biomedical and Genetics
Company: GENPREX
Industry: Medical - Biomedical and Genetics
Company: GENPREX
Industry: Medical - Biomedical and Genetics
Gene Therapy Platform Targeting Large Markets with Numerous Upcoming Milestone
Provider: Diamond Equity Research LLC
Analyst: DIAMOND H
Company: GENPREX
Industry: Medical - Biomedical and Genetics
Company: GENPREX
Industry: Medical - Biomedical and Genetics
Key Clinical Trials in Lung Cancer Launching in 2021
Provider: Diamond Equity Research LLC
Analyst: DIAMOND H
Company: GENPREX
Industry: Medical - Biomedical and Genetics
Financing Runway for Combination Trials with Top Selling Drugs
Provider: DIAMOND EQUITY RESEARCH LLC
Analyst: DIAMOND H
Company: GENPREX
Industry: Medical - Biomedical and Genetics
Financing Runway for Combination Trials with Top Selling Drugs
Provider: DIAMOND EQUITY RESEARCH LLC
Analyst: DIAMOND H
Company: GENPREX
Industry: Medical - Biomedical and Genetics
Cutting Edge Potential Gene Therapies Targeting Large Markets
Provider: DIAMOND EQUITY RESEARCH LLC
Analyst: DIAMOND H
Company: GENPREX
Industry: Medical - Biomedical and Genetics
Company: GENPREX
Industry: Medical - Biomedical and Genetics
Company: GENPREX
Industry: Medical - Biomedical and Genetics
The Waiting Game, Phase 1/2 Trial Results Still Key Inflection Point
Provider: DIAMOND EQUITY RESEARCH LLC
Analyst: DIAMOND H
Company: GENPREX
Industry: Unclassified
Initiation of Coverage - Innovative Gene Therapy Approach Within the Large Global Cancer Market
Provider: DIAMOND EQUITY RESEARCH LLC
Analyst: DIAMOND H